Clinical Feasibility of Minimally Supervised Therapy After Stroke With a Hand Rehabilitation Robot

NACompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

August 11, 2020

Primary Completion Date

September 14, 2023

Study Completion Date

September 14, 2023

Conditions
Stroke
Interventions
DEVICE

Minimally supervised therapy with the ReHapticKnob

The therapy with the ReHapticKnob is performed in the clinic in addition to the conventional therapy. During the supervised and semi-supervised phases (first 2 weeks), the intervention dose is 5 sessions of approximately 45 minutes per week. During each session, the robot proposes a set of 3 exercises, each lasting between 10 and 15 minutes. During the minimally supervised phase (third and fourth week), the duration of the ReHapticKnob therapy is not specified, since the patient can decide by him/herself when to use the device, e.g. during freetime or during the weekend.

Trial Locations (1)

6614

Clinica Hildebrand Centro di riabiliazione Brissago, Brissago

All Listed Sponsors
collaborator

Clinica Hildebrand Brissago

OTHER

collaborator

Rehabilitation Engineering Laboratory, ETHZ

UNKNOWN

lead

Swiss Federal Institute of Technology

OTHER

NCT04388891 - Clinical Feasibility of Minimally Supervised Therapy After Stroke With a Hand Rehabilitation Robot | Biotech Hunter | Biotech Hunter